The global flow cytometry market is expected to witness a CAGR of ~9% during the forecast period. High incidence and prevalence of HIV/AIDS and cancer, growing focus on immunology and immuno-oncology research, advent of AI platforms in flow cytometry workflows, increase in R&D investment to develop multicolor assays and advanced reagents are some of the key factors driving the market growth. However, higher costs of flow cytometry products is a major constraint for the growth of the flow cytometry market.
Flow cytometry is a technique used to detect and measure physical and chemical characteristics of a population of cells or particles usually suspended in a fluid using a laser beam. The technique helps in understanding the structure and composition of cells for chromosome analysis, cancer diagnosis, protein expression, diagnosis of diseases and hematological malignancies.
Most common types of flow cytometry-based proliferation assays are cell-based and bead-based assays. Today, cell-based assays are used in more than half of all high-throughput drug screenings for target validation and ADMET (absorption, distribution, metabolism, elimination and toxicity) in the early stage of drug discovery due to its enhanced accuracy and portability. On the other hand, Bead-based assays are used to study infectious diseases. Owing to advancements in molecular engineering and monoclonal antibody production, the demand for these assays is expected to rise in the coming years.
Furthermore, improvements in fluorescent dyes, advancements in multicolor flow cytometry (which finds extensive applications in new drug development), development of advanced reagents and AI based software platforms and algorithms are fueling the growth of the market.
Unlock key findings! Fill out a quick inquiry to access a sample report
https://meditechinsights.com/flow-cytometry-market/request-sample/
Rise in chronic disease increases flow cytometry utilization
Rising prevalence of chronic diseases such as cancer, HIV/AIDS, hematological malignancies and others is fueling the growth of the global flow cytometry market. Flow cytometry is considered an efficient tool for clinically diagnosing these diseases. The developments in immunology and other areas of cancer research have immensely contributed to the use of flow cytometry. Growing preference by health specialists to use allergenic and autologous stem cell therapies instead of radiation and chemotherapies is another key factor driving the market. Rising R&D investment by biotech and biopharma companies to introduce new technologies is also expected to propel the global flow cytometry market. For instance,
- In May 2024, Agilent Technologies introduced the NovoCyte Opteon Spectral Flow Cytometer, a system comprising 3-5 lasers, 73 detectors, enabling high-dimensional analysis of over 40 cellular markers with user-friendly software for diverse research applications
- In March 2024, Beckman Coulter Life Sciences launched the CytoFLEX Nano Flow Cytometer, an advanced platform optimized for high-sensitivity detection and characterization of extracellular vesicles and nanoparticles, providing researchers with enhanced resolution and analytical capabilities
Growing adoption of flow cytometry in stem cell research
Flow cytometry and cell sorting are critical tools in stem cell research. Recent advances in flow cytometric hardware, reagents and software have synergized to permit the stem cell biologist to better identify and isolating rare cells based on their immunofluorescence and light scattering characteristics. In contrast to other methods, such as Western blot and cellular imaging, multicolor flow cytometry enables researchers to interrogate heterogeneous cell populations and analyze their subpopulations. By using multiple fluorescent-labelled antibodies, researchers can obtain robust data and population-based statistics on differentiating stem cell cultures and isolate stem cells and their derivatives from primary tissue and diverse in-vitro populations.
There has been extraordinary growth in stem cell research and related applied clinical practices. The current flow cytometry applications in clinical research include emphasizing immunophenotyping, enumerating reticulocyte, reticulated platelet, multiple drug resistance assays, cell function assays and apoptosis. During pandemic, stem cell-based therapies were also recommended to manage or treat COVID-19 infections. The growing market penetration in stem cell research, adoption of recombinant DNA technology for antibody production, and evolution of tandem flow cytometry technologies is expected to open growth opportunities in the market.
“Flow Cytometry is turning researchers into molecular detectives and helping them to delve into the depths of diseases. It allows researchers and scientists to probe the more complex and transient cellular changes that underpin the course of disease and responses to treatment, helping them better select the right drug target”.
– Senior Director, Data Sciences & Quantitative Biology, Pharmaceutical & Biotechnology Company, United States
North America leads in terms of adoption of the flow cytometry market
North America dominates the global flow cytometry market, followed by Europe. Growing research activities, well-established infrastructure, rising drug discovery and development and presence of leading pharmaceutical companies in this region are some of the key factors driving the market growth.
In Asia Pacific, emerging economies like India and China are anticipated to grow significantly over the forecast period. Improving research infrastructure, adopting the latest technology and government support for establishing the pharmaceutical industry is likely to fuel the demand for the flow cytometry market in this region.
Competitive Landscape Analysis
The global flow cytometry market is marked by the presence of established and emerging market players such as Becton, Dickinson and Company; Danaher Corporation; Thermo Fisher Scientific, Inc.; DiaSorin S.p.A; Agilent Technologies, Inc.; Sony Group Corporation; Bio-Rad Laboratories, Inc.; Miltenyi Biotec GmbH; Apogee Flow Systems Ltd.; BioMérieux S.A.; Cytek Biosciences, Inc.; NanoCellect Biomedical, Inc., among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Get exclusive insights – download your sample report today
https://meditechinsights.com/flow-cytometry-market/request-sample/
Global Flow Cytometry Market Segmentation
This report by Medi-Tech Insights provides the size of the global flow cytometry market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, technology, application, and end-user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Instruments
- Cell Sorters
- Cell Analyzers
- Reagents & Consumables
- Software
- Accessories
Market Size & Forecast (2023-2030), By Technology, USD Million
- Cell-based
- Bead-based
Market Size & Forecast (2023-2030), By Application, USD Million
- Research
- Clinical
- Industrial
Market Size & Forecast (2023-2030), By End-user, USD Million
- Hospitals
- Academic & Research Institutes
- Biopharma Companies
- Clinical Labs
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
